It is a trading private limited company based in Delhi, Delhi, India, established in 2015.
2015 | Delhi, Delhi, India | ActiveGeoffery Pharmaceuticals Private Limited, a active private limited company, was established on 09 November 2015 in Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U51397DL2015PTC287218. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rajender Prashad Bansal (Director), Vishav Deep Bansal (Director). Past directors included Santosh Devi Bansal, Rajender Prashad Bansal, Sunny Mittal. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No.111, Block-I Pocket-4, Sector-16, First Floor, Rohini, Delhi, Delhi, 110085.
U51397DL2015PTC287218
287218
09 November 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Geoffery Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajender Prashad Bansal | Director | 07 Sep 2017 | Current |
| Vishav Deep Bansal | Director | 11 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Aug 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 31 Aug 2021 | Past |
| Pramod Abcsdd | Director | 07 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 07 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Geoffery Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 263.69% increase. The company also saw a substantial improvement in profitability, with a 51.43% increase in profit. The company's net worth Soared by an impressive increase of 89.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Geoffery Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Geoffery Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Geoffery Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geoffery Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vishav Deep Bansal was appointed as a Director was appointed as a Director on 11 Aug 2025 & has been associated with this company since 3 months 20 days . was documented.
The activity Geoffery Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
Progress on Geoffery Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Rajender Prashad Bansal was appointed as a Director was appointed as a Director on 07 Sep 2017 & has been associated with this company since 8 years 2 months . was recorded as a recent event.
Geoffery Pharmaceuticals Private Limited was registered on 09 Nov 2015 with Roc Delhi & aged 10 years 21 days as per MCA records. was recorded as a recent event.
The CIN of Geoffery Pharmaceuticals Private Limited is U51397DL2015PTC287218.
Geoffery Pharmaceuticals Private Limited is headquartered at House No.111, Block-I Pocket-4, Sector-16, First Floor, Rohini, Delhi, Delhi, 110085.
Geoffery Pharmaceuticals Private Limited was incorporated on 09 November 2015.
The current directors of Geoffery Pharmaceuticals Private Limited are
The primary industry of Geoffery Pharmaceuticals Private Limited is Trade.
Geoffery Pharmaceuticals Private Limited is unlisted.
The authorized capital of Geoffery Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Geoffery Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX